Stem cell therapy of Osteoporosis
Stem cell medical care for pathology might doubtless cut back the susceptibleness of fractures and augment lost mineral density by either increasing the numbers or restoring the operate of resident stem cells which will proliferate and differentiate into bone-forming cells. Such pathology therapies are often administrated by exogenous introduction of mesenchymal stem cells (MSCs), generally procured from bone marrow, adipose, and funiculus blood tissues or through treatments with medication or tiny molecules that recruit endogenous stem cells to osteoporotic sites.
- Tissue regeneration
- Cell transplantation
- Mesenchymal stem cells
- Amputations
Related Conference of Stem cell therapy of Osteoporosis
June 22-23, 2026
18th Global Neurologists Meeting on Neurology and Neurosurgery
Amsterdam, Netherlands
June 29-30, 2026
31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Paris, France
July 20-21, 2026
11th International Conference on Central Nervous System Disorders & Therapeutics
Amsterdam, Netherlands
July 23-24, 2026
14th International Conference on Cannabis & Medicinal Research
Amsterdam, Netherlands
September 17-18, 2026
31st Global Experts Meeting on Neuroscience and Neuropharmacology
Paris, France
April 27-28, 2027
18th International Conference on Stroke, Neurology and Cerebrovascular Diseases
Paris, France